Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 2016

View Archived Issues

drNPCs to treat neurological disorders

SPR-741 potentiates antibiotics against multidrug-resistant Gram-negative infections

FDA approves Abbott's Absorb absorbable stent for coronary heart disease

Arbutus Biopharma issues notice of termination to NeuroVive for NVP-018

FDA grants orphan drug designation for iBio-CFB03

Oryzon Genomics selects LSD1 inhibitor for preclinical development

Aviragen to license, develop and commercialize RSV inhibitors

Midostaurin shows promising clinical results for advanced systemic mastocytosis

Actelion initiates phase III TOMORROW study to evaluate macitentan in children with PAH

FDA grants fast track status to Merrimack's seribantumab

Takeda receives E.U. marketing authorization for Adcetris in third indication

Vertex, Moderna sign exclusive collaboration agreement for development of mRNA therapeutics for CF

Tolerogenic nanoparticles suppress spontaneous development of T1D in NOD mice

Bio-Techne to acquire Advanced Cell Diagnostics

ADT Pharmaceuticals announces RAS Gtpase inhibitors

Merck & Co. patents orexin receptor inhibitors

Roche and Genentech report ERalpha antagonists and destabilizers

Shanghai Haiyan Pharmaceutical Technology and Yangtze River Pharmaceutical disclose PI3K inhibitors

Celgene divulges ERK inhibitors

Alios BioPharma patents NS5B inhibitors

Revestive approved in Europe for pediatric patients with short bowel syndrome

Medivation enters confidentiality agreements with Sanofi and other companies

Amicus obtains rights to preclinical CDKL5 program through acquisition of MiaMed

FDA accepts Revive's IND for a phase II trial of bucillamine for cystinuria

New PREVAIL trial opens in Liberia for men with Ebola virus RNA detected in semen

Nanobiotix reports results for phase I/II trial of NBTXR-3

Asuragen launches AmplideX PCR/CE C9orf72 Kit

RHOA, CSNK1A1, DVL2, FZD8 and LRP5 may be useful as poor prognosis biomarkers in GC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...